DEXTROMETHORPHAN HBR, GUAIFENESIN

DEXTROMETHORPHAN HBR, GUAIFENESIN was reported 1018 times

DEXTROMETHORPHAN HBR, GUAIFENESIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ARTERIOGRAM CAROTID ABNORMAL 1 0.1111
1 BREAST CYST RUPTURE 1 0.0833
2 BLADDER ULCER 1 0.0244
3 MONONUCLEOSIS HETEROPHILE TEST POSITIVE 1 0.0185
4 HALLUCINATION, SYNAESTHETIC 1 0.0172
5 CITROBACTER TEST POSITIVE 1 0.0152
6 ALCOHOLIC SEIZURE 1 0.0135
7 BONE METABOLISM DISORDER 4 0.0133
8 INFUSION SITE HYPOAESTHESIA 1 0.0105
9 BRONCHOSCOPY ABNORMAL 1 0.0104
10 COMPULSIVE LIP BITING 1 0.0096
11 EAR, NOSE AND THROAT DISORDER 1 0.0071
12 ENDOMETRIAL CANCER STAGE I 1 0.0060
13 INTERNAL HERNIA 1 0.0060
14 INFUSION SITE INJURY 1 0.0057
15 ADMINISTRATION SITE DISCOMFORT 1 0.0053
16 GLOBAL AMNESIA 1 0.0047
17 IRREGULAR SLEEP PHASE 1 0.0047
18 COLD URTICARIA 1 0.0045
19 INFUSION SITE SCAR 2 0.0045
20 LOCKED-IN SYNDROME 2 0.0043
21 ELECTROCARDIOGRAM Q WAVE ABNORMAL 1 0.0043
22 CREST SYNDROME 1 0.0042
23 GENITAL DISCHARGE 1 0.0042
24 MOLE EXCISION 1 0.0041
25 BENIGN LUNG NEOPLASM 1 0.0040
26 BLADDER OBSTRUCTION 2 0.0039
27 EAR INFECTION BACTERIAL 1 0.0037
28 MORAXELLA INFECTION 1 0.0036
29 AUTOIMMUNE NEUTROPENIA 1 0.0035
30 URINARY TRACT INFECTION PSEUDOMONAL 2 0.0033
31 MUMPS 1 0.0032
32 EYE INFECTION VIRAL 1 0.0031
33 ADMINISTRATION SITE SWELLING 1 0.0031
34 CENTRAL SLEEP APNOEA SYNDROME 1 0.0031
35 COAGULATION TIME SHORTENED 1 0.0030
36 BRONCHITIS VIRAL 2 0.0030
37 PRODUCT DIFFICULT TO SWALLOW 3 0.0030
38 PREGNANCY OF PARTNER 2 0.0028
39 INFUSION SITE MASS 3 0.0028
40 SYSTEMIC SCLERODERMA 2 0.0027
41 FEEDING TUBE USER 1 0.0027
42 ACETABULUM FRACTURE 1 0.0027
43 ALLERGIC COUGH 2 0.0026
44 INFECTION PARASITIC 2 0.0026
45 DEPENDENCE ON RESPIRATOR 1 0.0025
46 BRONCHITIS ACUTE 1 0.0025
47 CHRONIC RESPIRATORY FAILURE 3 0.0025
48 GENITAL ABSCESS 1 0.0025
49 RENAL TUBULAR ACIDOSIS 5 0.0023
50 INFUSION SITE DISCOLOURATION 2 0.0023
51 HAEMORRHOID OPERATION 1 0.0022
52 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0022
53 ALLERGY TO ARTHROPOD STING 1 0.0022
54 ALLERGY TO PLANTS 1 0.0022
55 INFUSION SITE INFECTION 5 0.0021
56 DYSPHASIA 1 0.0021
57 DEVICE RELATED THROMBOSIS 2 0.0020
58 GASTROINTESTINAL FUNGAL INFECTION 1 0.0019
59 INJURY CORNEAL 1 0.0019
60 HYPERMETABOLISM 1 0.0019
61 FRACTURE PAIN 1 0.0019
62 INTERTRIGO 1 0.0018
63 MORNING SICKNESS 1 0.0018
64 HYPERTENSIVE URGENCY 1 0.0018
65 LIGAMENT INJURY 2 0.0018
66 ADMINISTRATION SITE PAIN 2 0.0017
67 HYPOAESTHESIA EYE 1 0.0017
68 ENDOSCOPY 1 0.0017
69 INFUSION RELATED HYPERSENSITIVITY REACTION 1 0.0017
70 BLOOD VISCOSITY INCREASED 1 0.0017
71 BRONCHITIS CHRONIC 4 0.0016
72 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 4 0.0016
73 POST-ACUTE COVID-19 SYNDROME 2 0.0016
74 BRONCHIAL SECRETION RETENTION 2 0.0016
75 CHALAZION 1 0.0016
76 BILIARY OBSTRUCTION 2 0.0015
77 FOREIGN BODY IN RESPIRATORY TRACT 2 0.0015
78 INFUSION SITE RASH 2 0.0015
79 MAST CELL ACTIVATION SYNDROME 2 0.0014
80 H1N1 INFLUENZA 2 0.0014
81 DERMATITIS DIAPER 1 0.0014
82 DYSHIDROTIC ECZEMA 1 0.0014
83 GENITAL PAIN 2 0.0014
84 CATHETER SITE RELATED REACTION 1 0.0013
85 MULTIPLE DRUG THERAPY 1 0.0013
86 BRONCHITIS BACTERIAL 1 0.0013
87 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
88 ENDOCARDITIS BACTERIAL 1 0.0013
89 ELECTROMECHANICAL DISSOCIATION 1 0.0013
90 CYSTITIS INTERSTITIAL 2 0.0012
91 INTERVERTEBRAL DISC SPACE NARROWING 1 0.0012
92 CHEMICAL INJURY 1 0.0012
93 SHOULDER FRACTURE 2 0.0012
94 CSF PROTEIN INCREASED 1 0.0012
95 ADRENAL MASS 1 0.0012
96 DEVELOPMENTAL HIP DYSPLASIA 1 0.0012
97 INCISION SITE COMPLICATION 1 0.0012
98 INFUSION SITE OEDEMA 1 0.0012
99 CRANIOFACIAL FRACTURE 1 0.0012
100 GINGIVAL ERYTHEMA 1 0.0012
101 SPINAL CORD INJURY 2 0.0011
102 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
103 PRODUCT SIZE ISSUE 6 0.0011
104 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
105 ESSENTIAL HYPERTENSION 2 0.0011
106 METASTATIC RENAL CELL CARCINOMA 2 0.0011
107 METASTASES TO ADRENALS 1 0.0011
108 CATHETER SITE SWELLING 1 0.0011
109 CHRONIC SINUSITIS 4 0.0011
110 BRAIN STEM HAEMORRHAGE 1 0.0011
111 INTRACRANIAL MASS 1 0.0011
112 INFUSION SITE NODULE 1 0.0010
113 BLADDER CATHETERISATION 1 0.0010
114 HAEMOPHILUS INFECTION 1 0.0010
115 DUST ALLERGY 1 0.0010
116 FOREIGN BODY 4 0.0010
117 AXILLARY MASS 1 0.0010
118 FOREIGN BODY IN THROAT 3 0.0010
119 DEVICE CONNECTION ISSUE 2 0.0009
120 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
121 HYPERTENSIVE NEPHROPATHY 1 0.0009
122 INTRACRANIAL VENOUS SINUS THROMBOSIS 1 0.0009
123 OCULOGYRIC CRISIS 2 0.0009
124 INFUSION SITE BRUISING 2 0.0009
125 SUSPECTED COVID-19 3 0.0009
126 COMPLEX PARTIAL SEIZURES 1 0.0009
127 PRODUCT PACKAGE ASSOCIATED INJURY 2 0.0009
128 MULTIPLE ALLERGIES 7 0.0009
129 GASTROINTESTINAL ULCER HAEMORRHAGE 1 0.0009
130 CYTOGENETIC ABNORMALITY 1 0.0009
131 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
132 ARTERIAL HAEMORRHAGE 1 0.0009
133 NEPHROGENIC ANAEMIA 4 0.0009
134 URINARY TRACT OBSTRUCTION 2 0.0008
135 PAINFUL RESPIRATION 2 0.0008
136 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
137 DEVICE INFUSION ISSUE 2 0.0008
138 FRACTURED COCCYX 1 0.0008
139 CANCER PAIN 2 0.0008
140 ABDOMINAL OPERATION 1 0.0008
141 PROSTATOMEGALY 3 0.0008
142 CLUSTER HEADACHE 1 0.0007
143 INTESTINAL MASS 1 0.0007
144 AGORAPHOBIA 1 0.0007
145 ORAL FUNGAL INFECTION 2 0.0007
146 DROOLING 5 0.0007
147 DRUG TOLERANCE DECREASED 2 0.0007
148 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
149 JUDGEMENT IMPAIRED 1 0.0007
150 PULMONARY PAIN 2 0.0007
151 CARDIAC FIBRILLATION 1 0.0007
152 APRAXIA 1 0.0007
153 CHOLANGIOCARCINOMA 1 0.0007
154 HYPOSMIA 1 0.0007
155 INFERTILITY 1 0.0007
156 REBOUND ACID HYPERSECRETION 2 0.0007
157 EYE INJURY 2 0.0007
158 EYE ALLERGY 1 0.0006
159 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
160 SEASONAL ALLERGY 9 0.0006
161 BREAST CANCER RECURRENT 2 0.0006
162 INAPPROPRIATE AFFECT 1 0.0006
163 COLON CANCER METASTATIC 1 0.0006
164 MICTURITION URGENCY 7 0.0006
165 SOMNAMBULISM 4 0.0006
166 INFUSION SITE HAEMORRHAGE 2 0.0006
167 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
168 BLOOD CALCIUM ABNORMAL 1 0.0006
169 MEDICAL PROCEDURE 1 0.0006
170 ARTHROPOD STING 1 0.0006
171 MITRAL VALVE PROLAPSE 1 0.0006
172 BRONCHIECTASIS 4 0.0006
173 INFUSION SITE ERYTHEMA 5 0.0006
174 LAZINESS 1 0.0006
175 INCREASED UPPER AIRWAY SECRETION 3 0.0006
176 MILIARIA 1 0.0006
177 TRISMUS 3 0.0006
178 INFUSION SITE DISCHARGE 1 0.0006
179 CHOKING 11 0.0006
180 PRODUCT CONTAMINATION 2 0.0006
181 HEREDITARY ANGIOEDEMA 6 0.0006
182 INJECTION SITE DISCHARGE 3 0.0006
183 BONE LESION 2 0.0006
184 SKIN LACERATION 6 0.0006
185 SCLERODERMA 2 0.0005
186 CHOKING SENSATION 3 0.0005
187 BODY TEMPERATURE ABNORMAL 1 0.0005
188 HYPERTRICHOSIS 1 0.0005
189 LYMPH NODE PAIN 1 0.0005
190 LIVING IN RESIDENTIAL INSTITUTION 1 0.0005
191 SNORING 2 0.0005
192 LIP DISORDER 1 0.0005
193 HYPERCOAGULATION 1 0.0005
194 ARTERIAL DISORDER 1 0.0005
195 CLAVICLE FRACTURE 2 0.0005
196 HEPATIC MASS 1 0.0005
197 ARTERIAL THROMBOSIS 1 0.0005
198 CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0005
199 GALLBLADDER INJURY 1 0.0005
200 VULVOVAGINAL MYCOTIC INFECTION 2 0.0005
201 BRADYKINESIA 3 0.0005
202 FUNGAL SKIN INFECTION 2 0.0005
203 EAR HAEMORRHAGE 1 0.0005
204 INGUINAL HERNIA 3 0.0005
205 EYELID PAIN 1 0.0005
206 IMPAIRED SELF-CARE 1 0.0005
207 MICROCYTIC ANAEMIA 1 0.0005
208 LUNG ABSCESS 1 0.0005
209 SENSATION OF FOREIGN BODY 4 0.0005
210 CATHETER SITE ERYTHEMA 1 0.0005
211 INFUSION SITE PAIN 6 0.0005
212 CARDIAC FLUTTER 3 0.0005
213 INCOHERENT 3 0.0005
214 PRODUCT FORMULATION ISSUE 3 0.0005
215 MIDDLE EAR EFFUSION 1 0.0005
216 RHINITIS ALLERGIC 2 0.0004
217 SKIN MASS 3 0.0004
218 CALCINOSIS 1 0.0004
219 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
220 OROPHARYNGEAL DISCOMFORT 4 0.0004
221 EYE INFECTION 5 0.0004
222 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
223 HAEMOGLOBIN INCREASED 2 0.0004
224 ONYCHOCLASIS 3 0.0004
225 BREAKTHROUGH PAIN 1 0.0004
226 MENOPAUSAL SYMPTOMS 1 0.0004
227 ROSACEA 2 0.0004
228 GESTATIONAL DIABETES 2 0.0004
229 HUMERUS FRACTURE 2 0.0004
230 INCORRECT DOSAGE ADMINISTERED 2 0.0004
231 HAEMATOLOGICAL INFECTION 1 0.0004
232 PHARYNGEAL SWELLING 4 0.0004
233 HOSPICE CARE 4 0.0004
234 HYPERVOLAEMIA 2 0.0004
235 FEELING DRUNK 3 0.0004
236 HEART INJURY 1 0.0004
237 GASTROINTESTINAL TUBE INSERTION 1 0.0004
238 HYPERPARATHYROIDISM SECONDARY 1 0.0004
239 CHROMATURIA 9 0.0004
240 EMPHYSEMA 4 0.0004
241 ECONOMIC PROBLEM 6 0.0004
242 DRY THROAT 4 0.0004
243 ABDOMINAL INFECTION 1 0.0004
244 INCREASED BRONCHIAL SECRETION 1 0.0004
245 THYROID DISORDER 6 0.0004
246 VARICOSE VEIN 2 0.0004
247 CATHETER SITE PAIN 1 0.0004
248 ACTINIC KERATOSIS 1 0.0004
249 FAILURE TO THRIVE 2 0.0004
250 COMPARTMENT SYNDROME 1 0.0004
251 ABDOMINAL MASS 1 0.0004
252 ABDOMINAL RIGIDITY 1 0.0004
253 ASPHYXIA 3 0.0004
254 LIP BLISTER 1 0.0004
255 POLYURIA 3 0.0004
256 SPINAL COMPRESSION FRACTURE 3 0.0004
257 ANAL HAEMORRHAGE 1 0.0004
258 ANGIOPATHY 2 0.0004
259 PRODUCTIVE COUGH 17 0.0004
260 JOINT LOCK 1 0.0004
261 IMPAIRED QUALITY OF LIFE 5 0.0003
262 EXERCISE TOLERANCE DECREASED 2 0.0003
263 SKIN ATROPHY 2 0.0003
264 FIBULA FRACTURE 1 0.0003
265 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
266 HYPERTONIC BLADDER 1 0.0003
267 RESPIRATORY TRACT INFECTION 9 0.0003
268 GASTROINTESTINAL NECROSIS 1 0.0003
269 DEVICE POWER SOURCE ISSUE 1 0.0003
270 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
271 HYPERCHLORHYDRIA 2 0.0003
272 ATYPICAL PNEUMONIA 1 0.0003
273 EMERGENCY CARE 1 0.0003
274 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
275 RETCHING 7 0.0003
276 DYSCHEZIA 1 0.0003
277 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
278 MENISCUS INJURY 2 0.0003
279 LARYNGEAL OEDEMA 2 0.0003
280 BRAIN DEATH 1 0.0003
281 SCOLIOSIS 2 0.0003
282 HAEMOPTYSIS 9 0.0003
283 DEMENTIA 9 0.0003
284 DELUSION 5 0.0003
285 INFUSION SITE EXTRAVASATION 2 0.0003
286 PRE-EXISTING CONDITION IMPROVED 2 0.0003
287 BLOOD CREATININE DECREASED 1 0.0003
288 NASAL DRYNESS 2 0.0003
289 INFUSION SITE PRURITUS 1 0.0003
290 SPINAL DISORDER 3 0.0003
291 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
292 DISEASE RECURRENCE 15 0.0003
293 RESPIRATORY TRACT CONGESTION 5 0.0003
294 PROCTALGIA 2 0.0003
295 HERNIA 6 0.0003
296 HIATUS HERNIA 4 0.0003
297 FACET JOINT SYNDROME 1 0.0003
298 LUNG DISORDER 15 0.0003
299 POLYP 2 0.0003
300 ORAL CANDIDIASIS 4 0.0003
301 LYME DISEASE 1 0.0003
302 CHOLECYSTITIS CHRONIC 2 0.0003
303 METASTASES TO SPINE 1 0.0003
304 POSTOPERATIVE WOUND INFECTION 2 0.0003
305 THROAT TIGHTNESS 8 0.0003
306 PRODUCT LABEL ISSUE 2 0.0003
307 DIABETIC RETINOPATHY 1 0.0003
308 B-CELL LYMPHOMA 1 0.0003
309 SINUSITIS 30 0.0003
310 BLOOD TESTOSTERONE DECREASED 2 0.0003
311 INFARCTION 2 0.0003
312 TEMPERATURE INTOLERANCE 3 0.0003
313 LEFT VENTRICULAR FAILURE 1 0.0003
314 BLOOD CREATININE ABNORMAL 1 0.0003
315 MICTURITION DISORDER 1 0.0003
316 HYPOPNOEA 1 0.0003
317 EAR PRURITUS 1 0.0003
318 INCONTINENCE 3 0.0003
319 COUGH 79 0.0003
320 GLOSSITIS 1 0.0003
321 DIVERTICULUM 2 0.0003
322 BRONCHOSPASM 4 0.0003
323 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
324 PHARYNGITIS STREPTOCOCCAL 3 0.0003
325 PANIC REACTION 2 0.0003
326 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
327 ASPIRATION 3 0.0003
328 FREEZING PHENOMENON 1 0.0003
329 ARTHROPOD BITE 2 0.0003
330 SKIN HAEMORRHAGE 4 0.0003
331 THROAT IRRITATION 12 0.0003
332 SKIN INFECTION 3 0.0003
333 HYDRONEPHROSIS 2 0.0003
334 HEPATIC NECROSIS 1 0.0003
335 LACRIMATION INCREASED 8 0.0003
336 DERMATITIS CONTACT 3 0.0003
337 INSURANCE ISSUE 4 0.0003
338 GASTRIC INFECTION 1 0.0003
339 RENAL FAILURE CHRONIC 2 0.0003
340 METASTASES TO LUNG 3 0.0003
341 CONCUSSION 2 0.0003
342 EPIGASTRIC DISCOMFORT 1 0.0003
343 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
344 PRODUCT USE COMPLAINT 4 0.0003
345 ABNORMAL DREAMS 7 0.0003
346 CYSTITIS 8 0.0003
347 CHRONIC KIDNEY DISEASE 19 0.0002
348 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
349 ENURESIS 1 0.0002
350 NOCTURIA 3 0.0002
351 BACK DISORDER 4 0.0002
352 DECUBITUS ULCER 2 0.0002
353 GOITRE 1 0.0002
354 DEMYELINATION 1 0.0002
355 BRONCHITIS 18 0.0002
356 RIB FRACTURE 5 0.0002
357 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
358 MUSCLE INJURY 2 0.0002
359 FUNGAL INFECTION 8 0.0002
360 DYSPHONIA 14 0.0002
361 HALLUCINATIONS, MIXED 1 0.0002
362 CANDIDA INFECTION 4 0.0002
363 HALLUCINATION, VISUAL 5 0.0002
364 URINARY INCONTINENCE 7 0.0002
365 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
366 CARDIAC FAILURE CHRONIC 1 0.0002
367 ABSCESS LIMB 1 0.0002
368 VITAMIN D DECREASED 2 0.0002
369 PSEUDOMONAS INFECTION 2 0.0002
370 MUSCLE STRAIN 2 0.0002
371 HORDEOLUM 1 0.0002
372 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
373 BONE CANCER 1 0.0002
374 LOCAL SWELLING 4 0.0002
375 IMMOBILE 1 0.0002
376 DIVERTICULUM INTESTINAL 1 0.0002
377 ANHEDONIA 6 0.0002
378 GASTRITIS 6 0.0002
379 TOOTH INFECTION 3 0.0002
380 PULMONARY CONGESTION 3 0.0002
381 COLD SWEAT 4 0.0002
382 INTENTIONAL DEVICE MISUSE 1 0.0002
383 BLOOD CREATINE INCREASED 1 0.0002
384 CATHETERISATION CARDIAC 1 0.0002
385 FACIAL PAIN 2 0.0002
386 THIRST 4 0.0002
387 SINUS CONGESTION 3 0.0002
388 PRODUCT TASTE ABNORMAL 3 0.0002
389 GASTROENTERITIS VIRAL 4 0.0002
390 GINGIVAL BLEEDING 3 0.0002
391 ABDOMINAL HERNIA 1 0.0002
392 EXOSTOSIS 2 0.0002
393 CORONARY ARTERY OCCLUSION 3 0.0002
394 EAR DISORDER 1 0.0002
395 PNEUMONIA BACTERIAL 2 0.0002
396 RETINAL DETACHMENT 2 0.0002
397 NIGHT SWEATS 7 0.0002
398 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
399 PRODUCT DISTRIBUTION ISSUE 2 0.0002
400 HEPATIC STEATOSIS 4 0.0002
401 CARPAL TUNNEL SYNDROME 3 0.0002
402 PHOTOPHOBIA 4 0.0002
403 DYSPNOEA EXERTIONAL 8 0.0002
404 GASTRIC ULCER 4 0.0002
405 URINARY RETENTION 7 0.0002
406 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
407 LIMB OPERATION 1 0.0002
408 COVID-19 36 0.0002
409 PARKINSONISM 2 0.0002
410 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
411 COELIAC DISEASE 2 0.0002
412 EXPIRED DRUG ADMINISTERED 1 0.0002
413 ANEURYSM 1 0.0002
414 UPPER LIMB FRACTURE 4 0.0002
415 APPLICATION SITE SWELLING 1 0.0002
416 HEPATIC ENZYME ABNORMAL 1 0.0002
417 AGEUSIA 5 0.0002
418 PNEUMONIA ASPIRATION 5 0.0002
419 OVARIAN CYST 2 0.0002
420 FLUID INTAKE REDUCED 1 0.0002
421 HALLUCINATION 15 0.0002
422 HYPOAESTHESIA ORAL 3 0.0002
423 CORONARY ARTERY STENOSIS 1 0.0002
424 PRODUCT COMPLAINT 5 0.0002
425 FEEDING DISORDER 4 0.0002
426 DYSLIPIDAEMIA 1 0.0002
427 AMMONIA INCREASED 1 0.0002
428 EUPHORIC MOOD 2 0.0002
429 EAR DISCOMFORT 2 0.0002
430 PNEUMONIA 63 0.0002
431 CEREBRAL ISCHAEMIA 1 0.0002
432 LYMPHOMA 3 0.0002
433 HYPERBILIRUBINAEMIA 2 0.0002
434 VENTRICULAR EXTRASYSTOLES 2 0.0002
435 EYE DISCHARGE 2 0.0002
436 PULMONARY HYPERTENSION 4 0.0002
437 BRAIN FOG 3 0.0002
438 ROAD TRAFFIC ACCIDENT 8 0.0002
439 WEIGHT FLUCTUATION 2 0.0002
440 PRODUCT ODOUR ABNORMAL 2 0.0002
441 SPEECH DISORDER 10 0.0002
442 SCRATCH 2 0.0002
443 HEAD INJURY 6 0.0002
444 RENAL PAIN 2 0.0002
445 JOINT INJURY 4 0.0002
446 RECTAL HAEMORRHAGE 8 0.0002
447 ASTHMA 21 0.0002
448 GINGIVITIS 1 0.0002
449 DECREASED ACTIVITY 2 0.0002
450 BEHAVIOUR DISORDER 1 0.0002
451 LIMB INJURY 5 0.0002
452 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
453 PRODUCT DISPENSING ERROR 4 0.0002
454 MULTIPLE FRACTURES 3 0.0002
455 JAW DISORDER 1 0.0002
456 EYE DISORDER 6 0.0002
457 RESPIRATORY DISTRESS 5 0.0002
458 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
459 PROCEDURAL PAIN 5 0.0002
460 GAIT INABILITY 6 0.0002
461 HEART RATE ABNORMAL 1 0.0002
462 ORAL PAIN 4 0.0002
463 CELLULITIS 9 0.0002
464 MITRAL VALVE INCOMPETENCE 2 0.0002
465 BLOOD PRESSURE INCREASED 27 0.0002
466 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
467 IMPAIRED DRIVING ABILITY 2 0.0002
468 INTERNAL HAEMORRHAGE 2 0.0002
469 CARDIAC VALVE DISEASE 1 0.0002
470 HYPERSOMNIA 5 0.0002
471 NIGHTMARE 6 0.0002
472 PERICARDIAL EFFUSION 4 0.0002
473 OROPHARYNGEAL PAIN 16 0.0002
474 DYSPEPSIA 17 0.0002
475 METABOLIC DISORDER 1 0.0002
476 SPLENOMEGALY 2 0.0002
477 RHINORRHOEA 11 0.0002
478 OSTEOPOROSIS 7 0.0002
479 NASAL CONGESTION 10 0.0002
480 ENERGY INCREASED 1 0.0002
481 WHEEZING 10 0.0002
482 CATARACT OPERATION 1 0.0002
483 CARDIAC PACEMAKER INSERTION 1 0.0002
484 OEDEMA 9 0.0002
485 LOCALISED INFECTION 4 0.0002
486 INJECTION SITE VESICLES 1 0.0002
487 BURSITIS 2 0.0002
488 BONE DISORDER 3 0.0002
489 END STAGE RENAL DISEASE 3 0.0002
490 RESTLESSNESS 6 0.0002
491 SMALL INTESTINAL OBSTRUCTION 2 0.0002
492 SPINAL OPERATION 2 0.0002
493 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
494 PHARYNGITIS 2 0.0002
495 CYST 2 0.0002
496 MIDDLE INSOMNIA 3 0.0002
497 DRY MOUTH 13 0.0002
498 SWOLLEN TONGUE 5 0.0002
499 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
500 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
501 SECRETION DISCHARGE 2 0.0002
502 HEPATIC CIRRHOSIS 3 0.0002
503 INFUSION SITE SWELLING 1 0.0002
504 DYSPHAGIA 15 0.0002
505 MUSCLE ATROPHY 2 0.0002
506 SLEEP APNOEA SYNDROME 3 0.0002
507 PULMONARY OEDEMA 7 0.0002
508 HIP FRACTURE 5 0.0002
509 SKIN ULCER 4 0.0002
510 EAR PAIN 3 0.0002
511 ANGINA UNSTABLE 1 0.0002
512 HAEMORRHOIDS 3 0.0002
513 NODULE 2 0.0002
514 KIDNEY INFECTION 3 0.0002
515 NASOPHARYNGITIS 28 0.0002
516 DISABILITY 3 0.0002
517 SINUS DISORDER 3 0.0002
518 CATARACT 9 0.0002
519 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
520 BLOOD PRESSURE ABNORMAL 3 0.0002
521 EYE HAEMORRHAGE 2 0.0001
522 QUALITY OF LIFE DECREASED 2 0.0001
523 FALL 49 0.0001
524 FEELING HOT 9 0.0001
525 ECCHYMOSIS 1 0.0001
526 SKIN LESION 4 0.0001
527 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
528 ILLNESS 15 0.0001
529 LYMPHOEDEMA 1 0.0001
530 LARGE INTESTINE PERFORATION 1 0.0001
531 POLLAKIURIA 6 0.0001
532 HYPERTRANSAMINASAEMIA 1 0.0001
533 FORMICATION 1 0.0001
534 FEELING COLD 4 0.0001
535 HUNGER 2 0.0001
536 NECK PAIN 8 0.0001
537 HYPOXIA 5 0.0001
538 PAIN IN JAW 4 0.0001
539 FEAR OF INJECTION 1 0.0001
540 RED BLOOD CELL COUNT DECREASED 4 0.0001
541 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
542 DYSPNOEA 79 0.0001
543 LETHARGY 8 0.0001
544 CARDIAC DISORDER 13 0.0001
545 AMNESIA 9 0.0001
546 ANOSMIA 2 0.0001
547 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
548 FAECES SOFT 1 0.0001
549 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
550 DYSSTASIA 4 0.0001
551 MAJOR DEPRESSION 1 0.0001
552 HYPOPHOSPHATAEMIA 1 0.0001
553 MEDICAL DEVICE COMPLICATION 1 0.0001
554 CONTUSION 13 0.0001
555 URINARY TRACT INFECTION 23 0.0001
556 GLOSSODYNIA 3 0.0001
557 RESPIRATORY DISORDER 4 0.0001
558 EPISTAXIS 10 0.0001
559 ATRIAL FIBRILLATION 13 0.0001
560 BLOOD POTASSIUM DECREASED 4 0.0001
561 HYPERHIDROSIS 17 0.0001
562 BLOOD COUNT ABNORMAL 2 0.0001
563 PRODUCT AVAILABILITY ISSUE 3 0.0001
564 NEPHROLITHIASIS 6 0.0001
565 PHARYNGEAL OEDEMA 2 0.0001
566 MUSCULOSKELETAL CHEST PAIN 2 0.0001
567 RENAL DISORDER 6 0.0001
568 HYPOALBUMINAEMIA 1 0.0001
569 DEVICE INFORMATION OUTPUT ISSUE 1 0.0001
570 SLEEP DISORDER 9 0.0001
571 AFFECTIVE DISORDER 1 0.0001
572 ARTHRITIS 10 0.0001
573 HAEMATOCHEZIA 7 0.0001
574 FURUNCLE 1 0.0001
575 GINGIVAL PAIN 1 0.0001
576 INFLUENZA 14 0.0001
577 MOBILITY DECREASED 9 0.0001
578 BLOOD PRESSURE FLUCTUATION 3 0.0001
579 BLOOD DISORDER 1 0.0001
580 OXYGEN SATURATION DECREASED 7 0.0001
581 FRUSTRATION TOLERANCE DECREASED 1 0.0001
582 ASTHENIA 46 0.0001
583 PHOTOSENSITIVITY REACTION 2 0.0001
584 RENAL FAILURE 16 0.0001
585 EXPIRED PRODUCT ADMINISTERED 4 0.0001
586 VIRAL INFECTION 4 0.0001
587 EOSINOPHIL COUNT INCREASED 1 0.0001
588 HOT FLUSH 9 0.0001
589 SURGERY 7 0.0001
590 EYE PRURITUS 4 0.0001
591 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
592 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
593 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
594 OSTEOARTHRITIS 5 0.0001
595 DIARRHOEA 76 0.0001
596 HYPOPHAGIA 3 0.0001
597 FACIAL PARALYSIS 1 0.0001
598 LOSS OF CONSCIOUSNESS 15 0.0001
599 FEELING ABNORMAL 28 0.0001
600 PERIPHERAL SWELLING 18 0.0001
601 MUSCULOSKELETAL DISCOMFORT 2 0.0001
602 PARANOIA 2 0.0001
603 BLOOD MAGNESIUM DECREASED 1 0.0001
604 BALANCE DISORDER 10 0.0001
605 NEUROPATHY PERIPHERAL 11 0.0001
606 CARDIAC MURMUR 1 0.0001
607 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
608 NEOPLASM PROGRESSION 4 0.0001
609 MENTAL DISORDER 5 0.0001
610 DISCOMFORT 7 0.0001
611 TREMOR 19 0.0001
612 APPLICATION SITE ERYTHEMA 3 0.0001
613 GROIN PAIN 1 0.0001
614 LUNG INFILTRATION 1 0.0001
615 HEAD DISCOMFORT 2 0.0001
616 INSOMNIA 30 0.0001
617 DEHYDRATION 15 0.0001
618 GALLBLADDER DISORDER 2 0.0001
619 BACK PAIN 26 0.0001
620 THROMBOSIS 9 0.0001
621 GASTROINTESTINAL INFECTION 1 0.0001
622 GOUT 2 0.0001
623 HEART RATE INCREASED 11 0.0001
624 PALLOR 3 0.0001
625 LIP DRY 1 0.0001
626 PELVIC PAIN 2 0.0001
627 RESTLESS LEGS SYNDROME 2 0.0001
628 TREATMENT NONCOMPLIANCE 6 0.0001
629 DEVICE DELIVERY SYSTEM ISSUE 3 0.0001
630 MEMORY IMPAIRMENT 15 0.0001
631 RESPIRATORY ARREST 3 0.0001
632 PRODUCT DOSE OMISSION ISSUE 32 0.0001
633 DYSURIA 4 0.0001
634 DIVERTICULITIS 3 0.0001
635 INJECTION SITE MASS 4 0.0001
636 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
637 WEIGHT DECREASED 30 0.0001
638 CHEST DISCOMFORT 11 0.0001
639 HEPATIC ENCEPHALOPATHY 1 0.0001
640 HAEMOGLOBIN DECREASED 11 0.0001
641 ABDOMINAL PAIN UPPER 22 0.0001
642 SWELLING 10 0.0001
643 FLANK PAIN 1 0.0001
644 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
645 TARDIVE DYSKINESIA 3 0.0001
646 LEUKAEMIA 1 0.0001
647 FLATULENCE 6 0.0001
648 BLOOD URINE PRESENT 2 0.0001
649 INTENTIONAL DOSE OMISSION 3 0.0001
650 MUSCULOSKELETAL DISORDER 2 0.0001
651 FEELING JITTERY 2 0.0001
652 EYE IRRITATION 6 0.0001
653 LOWER LIMB FRACTURE 2 0.0001
654 ACUTE RESPIRATORY FAILURE 2 0.0001
655 HYPERTENSION 22 0.0001
656 HYPERCHOLESTEROLAEMIA 1 0.0001
657 NEEDLE ISSUE 3 0.0001
658 INTENTIONAL PRODUCT MISUSE 9 0.0001
659 ORAL HERPES 2 0.0001
660 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
661 CHILLS 12 0.0001
662 SKIN FISSURES 2 0.0001
663 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
664 ANXIETY 29 0.0001
665 PAIN IN EXTREMITY 30 0.0001
666 KNEE OPERATION 1 0.0001
667 URTICARIA 17 0.0001
668 LIGAMENT SPRAIN 1 0.0001
669 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
670 ABNORMAL BEHAVIOUR 4 0.0001
671 DISORIENTATION 4 0.0001
672 CONSTIPATION 22 0.0001
673 PRESCRIBED UNDERDOSE 2 0.0001
674 HYPOTONIA 1 0.0001
675 DRY EYE 5 0.0001
676 INJURY 7 0.0001
677 HEPATIC FAILURE 3 0.0001
678 SOMNOLENCE 20 0.0001
679 PRODUCT PHYSICAL ISSUE 2 0.0001
680 CORONARY ARTERY DISEASE 3 0.0001
681 HYPOTHERMIA 1 0.0001
682 PLEURAL EFFUSION 6 0.0001
683 EYELID PTOSIS 1 0.0001
684 FLUID RETENTION 5 0.0001
685 ACUTE KIDNEY INJURY 15 0.0001
686 INITIAL INSOMNIA 1 0.0001
687 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
688 PRODUCT PREPARATION ERROR 2 0.0001
689 EMOTIONAL DISORDER 3 0.0001
690 LIMB DISCOMFORT 3 0.0001
691 INFLAMMATION 5 0.0001
692 INFECTION 14 0.0001
693 DEPRESSION 22 0.0001
694 DERMATITIS 2 0.0001
695 MOOD SWINGS 3 0.0001
696 PALPITATIONS 11 0.0001
697 BODY HEIGHT DECREASED 1 0.0001
698 MOVEMENT DISORDER 3 0.0001
699 IRRITABLE BOWEL SYNDROME 2 0.0001
700 LIVER FUNCTION TEST INCREASED 2 0.0001
701 POOR QUALITY SLEEP 2 0.0001
702 DISTURBANCE IN ATTENTION 5 0.0001
703 MUSCLE SPASMS 17 0.0001
704 UNEVALUABLE EVENT 7 0.0001
705 PYREXIA 32 0.0001
706 FAECES DISCOLOURED 2 0.0001
707 DIABETES MELLITUS 7 0.0001
708 INJECTION SITE NODULE 1 0.0001
709 APPLICATION SITE PAIN 2 0.0001
710 BLOOD PRESSURE DECREASED 6 0.0001
711 LIP SWELLING 3 0.0001
712 SKIN DISORDER 3 0.0001
713 SNEEZING 2 0.0001
714 PARAESTHESIA 14 0.0001
715 BLOOD CALCIUM DECREASED 1 0.0001
716 GAIT DISTURBANCE 17 0.0001
717 ANGER 3 0.0001
718 HEART RATE IRREGULAR 2 0.0001
719 MYOCARDIAL ISCHAEMIA 1 0.0001
720 HEADACHE 55 0.0001
721 CHOLECYSTECTOMY 1 0.0001
722 FATIGUE 68 0.0001
723 NAUSEA 69 0.0001
724 SKIN DISCOLOURATION 4 0.0001
725 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
726 GASTRIC HAEMORRHAGE 1 0.0001
727 CHEST PAIN 16 0.0001
728 EYELID OEDEMA 1 0.0001
729 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
730 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
731 LYMPHADENOPATHY 3 0.0001
732 COVID-19 PNEUMONIA 1 0.0001
733 ARRHYTHMIA 4 0.0001
734 HYPERLIPIDAEMIA 1 0.0001
735 HEPATIC CANCER 2 0.0001
736 IRRITABILITY 5 0.0001
737 JOINT SWELLING 10 0.0001
738 CEREBROVASCULAR ACCIDENT 14 0.0001
739 MENTAL IMPAIRMENT 2 0.0001
740 STOMATITIS 5 0.0001
741 NEURALGIA 2 0.0001
742 CARDIOMEGALY 1 0.0001
743 HYPERCALCAEMIA 1 0.0001
744 VOMITING 38 0.0001
745 OSTEONECROSIS OF JAW 2 0.0001
746 HYPERSENSITIVITY 15 0.0001
747 ILEUS 1 0.0001
748 CONFUSIONAL STATE 13 0.0001
749 HYPOAESTHESIA 12 0.0001
750 VISION BLURRED 11 0.0001
751 MUSCULAR WEAKNESS 9 0.0001
752 GASTRIC CANCER 2 0.0001
753 HAEMATEMESIS 2 0.0001
754 INJECTION SITE IRRITATION 1 0.0001
755 INJECTION SITE SWELLING 6 0.0001
756 DIZZINESS 39 0.0001
757 MYDRIASIS 1 0.0001
758 SEIZURE 9 0.0001
759 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
760 HAEMATOMA 2 0.0001
761 INJECTION SITE INDURATION 1 0.0001
762 DIPLOPIA 2 0.0001
763 PLASMA CELL MYELOMA 3 0.0001
764 PRODUCT USE IN UNAPPROVED INDICATION 19 0.0001
765 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
766 JOINT STIFFNESS 2 0.0001
767 BEDRIDDEN 1 0.0001
768 INFUSION RELATED REACTION 5 0.0001
769 MALAISE 33 0.0001
770 EAR INFECTION 2 0.0001
771 NEOPLASM MALIGNANT 5 0.0001
772 PAIN 46 0.0001
773 CARDIAC FAILURE 6 0.0001
774 CARDIAC FAILURE CONGESTIVE 6 0.0001
775 JOINT RANGE OF MOTION DECREASED 1 0.0001
776 FEAR 2 0.0001
777 EMOTIONAL DISTRESS 9 0.0001
778 OEDEMA PERIPHERAL 9 0.0001
779 DYSKINESIA 3 0.0001
780 BLINDNESS 3 0.0001
781 HEPATIC ENZYME INCREASED 5 0.0001
782 LUNG NEOPLASM MALIGNANT 3 0.0001
783 DEPENDENCE 4 0.0001
784 VISUAL IMPAIRMENT 9 0.0001
785 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
786 MENTAL STATUS CHANGES 2 0.0001
787 ARTHROPATHY 4 0.0001
788 HYPOMAGNESAEMIA 1 0.0001
789 APHONIA 1 0.0001
790 HOSPITALISATION 11 0.0001
791 WOUND 2 0.0001
792 ABDOMINAL DISCOMFORT 12 0.0001
793 WEIGHT INCREASED 16 0.0001
794 BLINDNESS UNILATERAL 1 0.0001
795 EYE PAIN 4 0.0001
796 RENAL FAILURE ACUTE 3 0.0001
797 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
798 SYNCOPE 7 0.0001
799 HERPES ZOSTER 4 0.0001
800 PANCREATIC CARCINOMA 2 0.0001
801 HYPOKINESIA 1 0.0001
802 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
803 FLUID OVERLOAD 1 0.0001
804 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
805 ANAEMIA 13 0.0001
806 ASCITES 2 0.0001
807 ACUTE MYOCARDIAL INFARCTION 2 0.0001
808 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
809 DRY SKIN 9 0.0001
810 DYSGEUSIA 5 0.0001
811 IMMUNODEFICIENCY 1 0.0001
812 ABDOMINAL DISTENSION 7 0.0001
813 GASTROINTESTINAL DISORDER 6 0.0001
814 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
815 BONE LOSS 1 0.0001
816 PRODUCT QUALITY ISSUE 9 0.0001
817 APHASIA 2 0.0001
818 SUICIDE ATTEMPT 4 0.0001
819 DEVICE FAILURE 1 0.0001
820 PLATELET COUNT DECREASED 7 0.0001
821 VERTIGO 4 0.0001
822 DRUG ADMINISTRATION ERROR 2 0.0001
823 DEVICE RELATED INFECTION 1 0.0001
824 HYPOTENSION 13 0.0001
825 MYALGIA 11 0.0001
826 BASAL CELL CARCINOMA 1 0.0001
827 BONE DENSITY DECREASED 2 0.0001
828 OCULAR HYPERAEMIA 3 0.0001
829 HALLUCINATION, AUDITORY 1 0.0001
830 MIGRAINE 6 0.0001
831 ABSCESS 1 0.0001
832 CONDITION AGGRAVATED 19 0.0001
833 PRURITUS 24 0.0001
834 MUSCLE TIGHTNESS 1 0.0001
835 RHEUMATOID ARTHRITIS 7 0.0001
836 DEEP VEIN THROMBOSIS 4 0.0001
837 SWELLING FACE 4 0.0001
838 INCORRECT DOSE ADMINISTERED 14 0.0001
839 CHOLELITHIASIS 2 0.0001
840 METASTASES TO BONE 1 0.0001
841 IMPAIRED HEALING 2 0.0001
842 MANIA 1 0.0001
843 INFLUENZA LIKE ILLNESS 5 0.0001
844 STAPHYLOCOCCAL INFECTION 2 0.0001
845 ARTHRALGIA 25 0.0001
846 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
847 CIRCULATORY COLLAPSE 1 0.0001
848 GASTRIC DISORDER 2 0.0001
849 RASH 25 0.0001
850 ECZEMA 3 0.0001
851 MUSCULOSKELETAL PAIN 3 0.0001
852 BURNING SENSATION 4 0.0001
853 HEART RATE DECREASED 2 0.0001
854 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
855 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
856 PRODUCT ADHESION ISSUE 2 0.0001
857 ABDOMINAL PAIN 13 0.0001
858 PANIC ATTACK 2 0.0001
859 RESPIRATORY FAILURE 4 0.0001
860 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
861 SUICIDAL IDEATION 5 0.0001
862 AGITATION 4 0.0001
863 ANAPHYLACTIC REACTION 3 0.0001
864 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
865 BLOOD GLUCOSE ABNORMAL 1 0.0001
866 CONJUNCTIVITIS 1 0.0001
867 AGRANULOCYTOSIS 1 0.0001
868 BACTERIAL INFECTION 1 0.0001
869 DYSARTHRIA 2 0.0001
870 INTESTINAL OBSTRUCTION 2 0.0001
871 BLOOD SODIUM DECREASED 1 0.0001
872 FRACTURE 1 0.0001
873 COLITIS 2 0.0001
874 FOOT FRACTURE 1 0.0001
875 ERUCTATION 1 0.0001
876 DYSTONIA 1 0.0001
877 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
878 BONE PAIN 3 0.0001
879 INJECTION SITE BRUISING 4 0.0001
880 FULL BLOOD COUNT DECREASED 1 0.0000
881 EXTRA DOSE ADMINISTERED 2 0.0000
882 BODY TEMPERATURE INCREASED 1 0.0000
883 INJECTION SITE PAIN 15 0.0000
884 ERYTHEMA 10 0.0000
885 EXPOSURE DURING PREGNANCY 3 0.0000
886 DRUG ABUSE 4 0.0000
887 RHABDOMYOLYSIS 2 0.0000
888 DRUG INEFFECTIVE 63 0.0000
889 KNEE ARTHROPLASTY 1 0.0000
890 MOUTH ULCERATION 1 0.0000
891 SKIN EXFOLIATION 4 0.0000
892 IMPAIRED WORK ABILITY 1 0.0000
893 HYPOACUSIS 2 0.0000
894 DEATH 40 0.0000
895 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
896 VAGINAL HAEMORRHAGE 2 0.0000
897 PSORIASIS 6 0.0000
898 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
899 PRODUCT STORAGE ERROR 4 0.0000
900 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
901 MELAENA 1 0.0000
902 ANGIOEDEMA 2 0.0000
903 LIVER DISORDER 2 0.0000
904 SEPSIS 5 0.0000
905 DEVICE ISSUE 4 0.0000
906 APPLICATION SITE PRURITUS 1 0.0000
907 SKIN IRRITATION 2 0.0000
908 INJECTION SITE REACTION 3 0.0000
909 TINNITUS 2 0.0000
910 MUSCLE TWITCHING 1 0.0000
911 HYPOKALAEMIA 2 0.0000
912 DECREASED APPETITE 10 0.0000
913 BLOOD CHOLESTEROL INCREASED 2 0.0000
914 COGNITIVE DISORDER 2 0.0000
915 PRODUCT USE ISSUE 8 0.0000
916 DISEASE PROGRESSION 5 0.0000
917 PULMONARY EMBOLISM 4 0.0000
918 MULTIPLE SCLEROSIS 2 0.0000
919 BLOOD GLUCOSE DECREASED 2 0.0000
920 UNDERDOSE 3 0.0000
921 ABASIA 1 0.0000
922 EXTRAPYRAMIDAL DISORDER 1 0.0000
923 MYOCARDIAL INFARCTION 7 0.0000
924 OFF LABEL USE 35 0.0000
925 EXPOSURE VIA SKIN CONTACT 1 0.0000
926 HAEMORRHAGE 4 0.0000
927 DEAFNESS 1 0.0000
928 DEPRESSED MOOD 2 0.0000
929 DRUG INTERACTION 6 0.0000
930 BRADYCARDIA 2 0.0000
931 INJECTION SITE HAEMORRHAGE 3 0.0000
932 JAUNDICE 1 0.0000
933 DRUG EFFECT DECREASED 2 0.0000
934 OVERDOSE 8 0.0000
935 NEUTROPENIA 5 0.0000
936 MOOD ALTERED 1 0.0000
937 CARDIAC ARREST 3 0.0000
938 THROMBOCYTOPENIA 4 0.0000
939 RENAL IMPAIRMENT 3 0.0000
940 BLISTER 2 0.0000
941 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
942 CONVULSION 2 0.0000
943 ANGINA PECTORIS 1 0.0000
944 PRODUCT SUBSTITUTION ISSUE 2 0.0000
945 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
946 MUSCULOSKELETAL STIFFNESS 3 0.0000
947 LABORATORY TEST ABNORMAL 1 0.0000
948 ADVERSE EVENT 3 0.0000
949 FEMUR FRACTURE 1 0.0000
950 DRUG-INDUCED LIVER INJURY 1 0.0000
951 BLOOD CREATININE INCREASED 2 0.0000
952 DRUG DOSE OMISSION 5 0.0000
953 INJECTION SITE PRURITUS 2 0.0000
954 TOXICITY TO VARIOUS AGENTS 5 0.0000
955 FLUSHING 3 0.0000
956 HAEMATURIA 1 0.0000
957 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
958 DELIRIUM 1 0.0000
959 DEVICE MALFUNCTION 2 0.0000
960 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
961 THERAPY INTERRUPTED 2 0.0000
962 SKIN BURNING SENSATION 2 0.0000
963 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
964 MYELOSUPPRESSION 1 0.0000
965 DRUG EFFECT INCOMPLETE 1 0.0000
966 CRYING 1 0.0000
967 HYPERGLYCAEMIA 1 0.0000
968 ACCIDENTAL OVERDOSE 1 0.0000
969 BLOOD GLUCOSE INCREASED 5 0.0000
970 ACNE 2 0.0000
971 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
972 DRUG DOSE OMISSION BY DEVICE 2 0.0000
973 DRUG DEPENDENCE 4 0.0000
974 INJECTION SITE ERYTHEMA 3 0.0000
975 DEVICE DISLOCATION 1 0.0000
976 DRUG WITHDRAWAL SYNDROME 2 0.0000
977 TACHYCARDIA 2 0.0000
978 COMA 1 0.0000
979 INTERSTITIAL LUNG DISEASE 1 0.0000
980 DERMATITIS ATOPIC 1 0.0000
981 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
982 MEDICATION ERROR 1 0.0000
983 ILL-DEFINED DISORDER 1 0.0000
984 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
985 INTENTIONAL OVERDOSE 1 0.0000
986 FEBRILE NEUTROPENIA 1 0.0000
987 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
988 ADVERSE DRUG REACTION 1 0.0000
989 NO ADVERSE EVENT 2 0.0000
990 BREAST CANCER 1 0.0000
991 ALOPECIA 2 0.0000
992 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000